ProPharma Group and The Planet Group announce unified brand and expanded capabilities. Learn more >

ProPharma Group is the leading global, independent, single-source provider of regulatory, clinical, and compliance services serving pharmaceutical, biotechnology, and medical device companies. Our team of experts brings a comprehensive portfolio of regulatory sciences, clinical research solutions, life science consulting, pharmacovigilance, and medical information services to help solve complex challenges in a dynamic regulatory environment. With our mission to improve the health and safety of patients, we are focused on delivering the highest quality of services throughout the full product lifecycle.

Quote

Working in close partnership with our clients to improve the health and safety of patients, our global teams are committed to quality and excellence in everything we do to support clients throughout the full product lifecycle.

Michael Stomberg
Chief Executive Officer
Michael Stomberg
Chief Executive Officer

Fast Facts

395+ Bilingual Native Speakers

Our fully integrated Medical Information contact centers span 4 continents with a team of 395+ bilingual native speakers covering 32+ languages

Presence Across 6 Continents

Providing critical support services to global pharmaceutical, biotechnology, and medical device clients across 6 continents

2000+ Strong and Counting

From 27 offices in 10 countries, our growing team of 2000+ professionals provide the highest quality of services on a global scale supported by regional expertise

Company History

2021

  • Acquired iSafety Systems, a leading pharmacovigilance provider headquartered in India’s leading bio-tech hub, Hyderabad.
  • ProPharma Group and The Planet Group, a leading provider of specialized consulting services and outsourced human capital solutions to the Life Sciences, Energy/Engineering and Technology sectors, announced an agreement to merge the two companies.
  • Acquired Diamond Pharma Services, a leading regulatory sciences, pharmacovigilance, and compliance and quality consultancy headquartered in the UK, with offices in Europe.

2019

  • Expanded our support for clients throughout all phases of the product lifecycle with the acquisitions of The Weinberg Group, a leading provider of regulatory sciences based in the United States and Southwood Research, a pre-approval regulatory science services provider based in the United Kingdom.
  • United Xendo, Sofus Regulatory Affairs, and SOLUTIONS in Health under the global ProPharma Group brand.

2018

  • Acquired SOLUTIONS in Health, a Canada-based provider of medical information services.
  • Further expanded our global support capabilities, with a new contact center in Fort Washington, PA.
  • Expanded our global reach and service offerings for compliance consulting, regulatory sciences, and pharmacovigilance with the acquisition of European-based Xendo, which included Sofus Regulatory Affairs.

2017

  • Further expanded our pharmacovigilance services with the acquisition of Drug Safety Solutions, a clinical safety company, based in the United States.
  • Expanded global support with new contact center in Tokyo, Japan.

2015

Acquired the leading provider of pharmacovigilance services, PROSAR, based in the United States, to complement our suite of MI services.

2014

Further expanded our medical information capabilities with the acquisition of Professional Information Ltd (PI) operating in the United Kingdom and Australia.

2011

Expanded our suite of services to include medical information with the acquisition of Advanced Response Management (ARM), based in the United States.

2007

Joined forces with Computer Compliance to deliver an enhanced experience in validation of automated systems, computers, and IT services.

2001

Established as a leading provider of validation and other related life science consulting services in the pharmaceutical, biotechnology, and medical device industries.

Dawn Sherman

Chairman of the Board

Quote

ProPharma Group is very fortunate to have an exceptional leadership team with deep industry experience as well as passion and drive around our higher purpose of improving patient health and safety.

Our Leadership Team

Michael Stomberg

Chief Executive Officer

Jason DeGoes

President, ProPharma Group

Tim Bauwens

Chief Financial Officer

Carolyn Durham

Chief Operating Officer

Joe Donnici

Chief Information Officer

Rachel Bias

Chief Human Resources Officer

Sara Sorrentino

Executive Vice President, Global Business Development

Matthew Weinberg

President, Regulatory Sciences

Jim Kolbet

President, Life Science Consulting

Kevin Wysocki

President, Clinical Research Solutions

Dennis Schonbachler

President, Pharmacovigilance

Rajul Jain

President, Medical Information

Joe Biehl

President, Key Accounts

Jean Marie Thompson

Vice President, Marketing

Kristin Ortlieb

Vice President, Compliance

Carl Barker

Vice President Finance, Europe

Nick Littlebury

Vice President, European Regulatory Operations

Tom Oakley

Vice President, European Regulatory Development

Eleonora Casucci

Vice President, European Life Science Consulting

Thomas Chatzopoulos

Vice President, Global Pharmacovigilance


Looking to Ensure Regulatory and Development Success Throughout the Lifespan of Your Product?

Contact us to learn more about how we can help you at every step of the product development lifecycle to improve patient health and safety.

Interested in gaining an industry edge? Let us help you stay current.


All fields are required.
There was a problem with your submission. Errors have been highlighted below.